Mesoblast (MESO) Operating Expenses (2015 - 2023)

Mesoblast's Operating Expenses history runs 9 years deep, the most recent figure standing at $73.3 million for Q2 2023.

• In Q2 2023, Operating Expenses rose 20.99% year-over-year to $73.3 million; the TTM figure through Dec 2024 stood at $73.3 million (down 90.96% YoY), while the FY2025 annual figure was $74.1 million, up 14.56% from the prior year.
• Operating Expenses came in at $73.3 million for Q2 2023 at Mesoblast, up from -$7.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.6 billion in Q1 2021 to a low of -$6.6 billion in Q2 2021.
• A 5-year average of -$101.9 million and a median of $67.0 million in 2022 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses tumbled 16992.02% in 2020 and surged 5698.1% in 2021, its largest moves.
• Mesoblast's Operating Expenses stood at $650.5 million in 2019, then tumbled by 102.19% to -$14.2 million in 2020, then soared by 5698.1% to $797.1 million in 2021, then retreated by 6.61% to $744.4 million in 2022, then tumbled by 90.15% to $73.3 million in 2023.
• According to Business Quant data, Operating Expenses over the past three periods registered $73.3 million, -$7.1 million, and $744.4 million for Q2 2023, Q1 2023, and Q4 2022 respectively.

Peer Comparison